ArticleInternational journal of general medicine2025

Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer.

Zongjian Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.